Cantitate/Preț
Produs

Alternative Splicing and Disease: Progress in Molecular and Subcellular Biology, cartea 44

Editat de Philippe Jeanteur
en Limba Engleză Paperback – 30 noi 2010
Splicing of primary RNA transcript, i.e. removal of introns and joining of exons to produce mature mRNAs competent for translation into proteins, is a quasi-systematic step of gene expression in higher organisms. However, this process is not unequivocal but can follow alternate pathways. Alternative splicing of a given transcript can therefore yield several distinct mRNAs encoding as many different proteins. Its full biological significance has not been appreciated until it was recognized that alternative splicing is so general as to affect about 75% of all human genes. Therefore, alternative splicing not only vastly increases protein diversity but also offers numerous opportunities for aberrant splicing events with pathological consequences.
Citește tot Restrânge

Din seria Progress in Molecular and Subcellular Biology

Preț: 118787 lei

Preț vechi: 144862 lei
-18%

Puncte Express: 1782

Carte tipărită la comandă

Livrare economică 08-22 iulie

Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.

Specificații

ISBN-13: 9783642070815
ISBN-10: 3642070817
Pagini: 272
Ilustrații: XII, 257 p. 26 illus., 2 illus. in color.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.42 kg
Ediția:Softcover reprint of hardcover 1st edition 2006
Editura: Springer
Colecția Progress in Molecular and Subcellular Biology
Seria Progress in Molecular and Subcellular Biology

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

Methods and Platforms for the Quantification of Splice Variants' Expression.- Pre-mRNA Missplicing as a Cause of Human Disease.- Alternative Splicing: Therapeutic Target and Tool.- SR Proteins as Potential Targets for Therapy.- Misregulation of Tau Alternative Splicing in Neurodegeneration and Dementia.- Spinal Muscular Atrophy and Therapeutic Prospects.- Misregulation of Alternative Splicing Causes Pathogenesis in Myotonic Dystrophy.- Redirecting Splicing to Address Dystrophin Mutations: Molecular By-pass Surgery.- Altered Splicing in Prelamin A-Associated Premature Aging Phenotypes.- Splicing Modulation as a Modifier of the CFTR Function.

Textul de pe ultima copertă

Splicing of primary RNA transcript, i.e. removal of introns and joining of exons to produce mature mRNAs competent for translation into proteins, is a quasi-systematic step of gene expression in higher organisms. However, this process is not unequivocal but can follow alternate pathways. Alternative splicing of a given transcript can therefore yield several distinct mRNAs encoding as many different proteins. Its full biological significance has not been appreciated until it was recognized that alternative splicing is so general as to affect about 75% of all human genes. Therefore, alternative splicing not only vastly increases protein diversity but also offers numerous opportunities for aberrant splicing events with pathological consequences.

Caracteristici

First book to highlight the medical implications, i.e. diseases, caused by alternative splicing Outlines possible targets for therapy Written by internationally reknown experts Includes supplementary material: sn.pub/extras